Hemoglobin E disease is a genetic blood disorder that affects how red blood cells carry oxygen. People with Hemoglobin E disease often have mild anemia and may feel tired or short of breath with exertion. Many living with Hemoglobin E disease have few signs, and the condition usually lasts lifelong. It is more common in people with Southeast Asian ancestry, and children are often diagnosed after a routine blood test. Treatment is usually not needed, but doctors may recommend folic acid, vaccines, and regular checkups, and the outlook is generally good with normal life expectancy.
Overview
Hemoglobin e diseaseSymptoms
Hemoglobin E disease often causes no symptoms. Some people notice mild anemia features like tiredness, pale skin, or slight yellowing of the eyes, sometimes with a mildly enlarged spleen. Doctors may find small red blood cells on tests.
Outlook and prognosis
Most people with Hemoglobin E disease have a stable, mild course and live a typical lifespan. Many feel well between occasional tiredness or mild anemia, though children may need extra monitoring during growth or infections. Regular checkups help prevent complications like gallstones or iron overload.
Causes and risk factors
Hemoglobin e disease results from inherited changes in the beta-globin gene, usually when both parents pass on a Hemoglobin E variant. Risk rises with family history and Southeast Asian ancestry; illness, pregnancy, and poor nutrition can worsen anemia.
Genetic influences
Genetics is central in Hemoglobin E disease. It happens when someone inherits Hemoglobin E variants from both parents; carriers usually have mild or no symptoms. Different genetic combinations (e.g., HbE with beta-thalassemia) can change severity and management.
Diagnosis
Clinicians suspect it from anemia signs and a blood count with small red cells. Hemoglobin electrophoresis or HPLC confirms HbE; newborn screening often detects it. Genetic diagnosis of Hemoglobin e disease uses HBB testing, plus family history review.
Treatment and drugs
Treatment for Hemoglobin E disease depends on severity. Many need routine checkups, folic acid, and vaccines; some benefit from avoiding iron unless deficiency is proven. When anemia is significant, care may include transfusions, chelation, and specialist monitoring.
Symptoms
Many people with Hemoglobin E disease feel well most of the time. When features do appear, they usually relate to mild anemia and the body breaking down red blood cells faster than usual, and early features of Hemoglobin E disease are often subtle. Features vary from person to person and can change over time. Signs tend to be milder in Hemoglobin E disease and more noticeable when Hemoglobin E is combined with beta thalassemia.
Many with Hemoglobin E disease have no obvious problems, especially with the homozygous form. Features may be found only on a routine blood test.
Feeling unusually tired or lacking stamina can come from mild anemia in Hemoglobin E disease. It may be more noticeable during illness, pregnancy, or growth spurts. In daily routines, this might show up as small but noticeable changes.
Skin, inner eyelids, or gums can look paler than usual from lower hemoglobin. This can be easier to spot on the lips, nail beds, or palms, and on the gums or eyes in darker skin.
A yellow tinge to the eyes or skin can happen when red blood cells break down faster than usual. Clinicians call this jaundice, which means bilirubin is building up in the body. It may come and go, and can be more obvious during infections.
How people usually first notice Hemoglobin e disease?
Many families first notice hemoglobin E disease after a routine blood test shows mild anemia or “small red cells,” often during a child’s first check-ups or when a parent is screened in pregnancy. Babies usually look well at birth, but as infants or toddlers they may have pale skin, tiredness with play, or slow weight gain, which prompts testing and reveals the first signs of hemoglobin E disease. In areas where carrier screening is common or when there’s a family history, the condition is often first noticed through prenatal or newborn screening before symptoms appear.
Types of Hemoglobin e disease
Hemoglobin E disease has a few well-recognized variants based on which hemoglobin genes are inherited together. These variants can lead to differences in anemia severity, red blood cell size, and whether jaundice or an enlarged spleen shows up. Symptoms don’t always look the same for everyone. Knowing the types of Hemoglobin E disease can help make sense of test results and everyday impacts like energy levels or exercise tolerance.
Hemoglobin E trait
Usually no symptoms. People often learn about it from a routine blood test showing small red cells. Not everyone will experience every type.
Hemoglobin E disease
Mild anemia is common with small red blood cells. Some notice mild jaundice or a slightly enlarged spleen during illness or stress.
Hemoglobin E/beta-plus thalassemia
Typically mild to moderate anemia with small red cells. People may have jaundice, gallstones risk, and exercise intolerance, especially during infections.
Hemoglobin E/beta-zero thalassemia
Often moderate to severe anemia. Children may need regular transfusions, and doctors monitor growth, spleen size, and iron levels.
Hemoglobin E with alpha-thalassemia
Anemia severity varies depending on how many alpha genes are affected. Symptoms range from minimal to moderate, with small red cells on testing. These variants of Hemoglobin E disease help explain the different types of Hemoglobin E-related anemia.
What genetics can tell you about symptoms
People with Hemoglobin E disease often have mild anemia, tiredness, and sometimes jaundice, because the HBB gene’s HbE change makes red blood cells smaller and more fragile. When HbE pairs with another variant like beta‑thalassemia, symptoms can be more pronounced.
Causes and risk factors
The cause is a change in the beta‑globin gene that makes hemoglobin E.
Hemoglobin E disease develops when you inherit the change from both parents, or when it pairs with a beta‑thalassemia trait.
Risk is higher if your family carries these traits and if you have roots in Southeast or South Asia.
Infections, low folate, pregnancy, and high altitude can worsen anemia and symptoms in Hemoglobin E disease.
Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
For Hemoglobin E disease, risks that come from the body or environment are limited. Doctors often group risks into internal (biological) and external (environmental). Most common exposures during pregnancy or birth have not been shown to raise the chance of this condition. If you’re reading about early symptoms of Hemoglobin E disease, remember those describe health after birth rather than what makes the condition more likely.
Common exposures such as air pollution, heavy metals, radiation, or hormone-disrupting chemicals have not been shown to increase the chance of Hemoglobin E disease. Current evidence links these exposures to other health issues, not to the occurrence of this condition.
Advanced maternal or paternal age has no clear association with Hemoglobin E disease. Unlike some chromosomal conditions, older parental age does not appear to raise its likelihood.
Typical infections during pregnancy have not been linked to causing this condition. They may affect pregnancy or newborn health in other ways, but not whether this condition is present.
Common conditions such as diabetes, high blood pressure, or thyroid disease do not increase the chance of Hemoglobin E disease. Managing these conditions is important for overall pregnancy health but does not change whether this condition occurs.
Genetic risk factors
Hemoglobin E disease stems from changes in the beta-globin gene that affect how hemoglobin is made. Genetic risk factors for Hemoglobin E disease include inheriting two HbE copies or one HbE copy together with a beta-thalassemia change. Risk is not destiny—it varies widely between individuals. Family background and ancestry patterns influence who carries these variants, and combinations with other blood gene changes shape severity.
HBB gene change: The HbE variant is a small change in the beta-globin (HBB) gene that alters hemoglobin structure and reduces its production. Inheriting this change twice can lead to smaller red cells and mild anemia.
Autosomal recessive: Hemoglobin E disease occurs when a child inherits an HbE variant from both parents. Carriers with one HbE copy usually have no symptoms but can pass it on.
Carrier-parent risk: When both parents carry HbE, each pregnancy has a 25% chance of Hemoglobin E disease. There is also a 50% chance the child will be a carrier, and a 25% chance of neither copy.
HbE/beta-thalassemia: One HbE copy plus a beta-thalassemia change on the other gene can cause a more serious form than homozygous HbE. The exact severity depends on the beta-thalassemia type.
Ancestry patterns: HbE is more common in families with Southeast Asian, South Asian, or southern Chinese roots, raising the chance of two carriers having a child together. Migration means carriers are now found worldwide.
Family history: Having relatives with HbE trait or Hemoglobin E disease increases your odds of being a carrier. Testing can clarify who in a family carries the variant.
Related parents: Parents from the same extended family have a higher chance of sharing HbE, which increases the risk of Hemoglobin E disease in children. This is due to shared genetic background.
Genetic modifiers: Inherited factors that raise fetal hemoglobin can ease anemia in HbE/beta-thalassemia, while others can make it worse. These modifiers help explain why symptoms differ between people with similar genotypes.
Alpha-thalassemia mix: Carrying alpha-thalassemia along with HbE can change red cell size and the degree of anemia. In some combinations it may lessen severity, while in others it complicates the picture.
Lifestyle risk factors
Hemoglobin e disease is inherited; lifestyle habits do not cause it, but they can influence symptoms, anemia-related fatigue, iron buildup, and complication risks. Below are practical ways lifestyle affects Hemoglobin e disease in day-to-day management. In particular, diet choices, activity patterns, and substance use can change iron balance, cardiorespiratory strain, and gallstone risk. These are the lifestyle risk factors for Hemoglobin e disease most clinicians discuss with patients.
People with Hemoglobin e disease can absorb iron more readily, so frequent high-iron foods may add to iron overload. Choose lower-iron options and avoid iron-fortified products unless your clinician advises otherwise.
Vitamin C boosts iron absorption from meals and supplements. If iron levels are high, avoid pairing vitamin C–rich foods or drinks with iron-heavy meals.
Tea and coffee polyphenols modestly reduce non-heme iron absorption. Having them with meals can help blunt iron uptake in Hemoglobin e disease.
Ongoing red blood cell turnover in Hemoglobin e disease raises folate needs. Folate-rich foods or prescribed folic acid may support erythropoiesis and reduce anemia-related fatigue.
Risk prevention
Hemoglobin E disease is inherited, so you can’t prevent the condition after conception, but you can lower the chance of passing it on and reduce complications if you or your child has it. Some prevention is universal, others are tailored to people with specific risks. Planning before pregnancy, timely screening, and everyday habits that protect red blood cells can make a real difference. For many, this means staying up to date on vaccines, checking iron levels before taking supplements, and knowing when to seek care for fevers or worsening anemia.
If you have Southeast Asian, South Asian, or mixed ancestry, ask for hemoglobinopathy carrier testing before pregnancy. If one partner carries Hemoglobin E and the other carries beta thalassemia or another variant, a genetic counselor can explain reproductive options.
Make sure your baby has newborn screening and confirmatory tests if a result suggests hemoglobin E disease. Early referral to a hematology clinic can help prevent avoidable complications.
Keep routine vaccines current, including flu and pneumococcal shots if recommended, to lower infection risk. This is especially important for people with hemoglobin E disease who have a large spleen or have had the spleen removed.
Daily folate helps your body make healthy red blood cells and may reduce anemia symptoms. People with hemoglobin E disease and those planning pregnancy should ask about the right dose.
Transmission
Hemoglobin E disease is not contagious; it can’t be caught from someone else. It is passed down in an autosomal recessive way: when both parents carry the HbE trait, each pregnancy has a 25% chance of a child with Hemoglobin E disease (EE), a 50% chance the child will be a carrier, and a 25% chance of neither. If one parent carries HbE and the other carries beta thalassemia, there is a 25% chance with each pregnancy of Hemoglobin E/beta thalassemia, a related condition that can be more serious. New genetic changes can occur but are uncommon; most families learn about how Hemoglobin E disease is inherited through carrier testing. A genetic counselor can explain the genetic transmission of Hemoglobin E disease and your family’s chances in more detail.
When to test your genes
Consider genetic testing if you have anemia that doesn’t fit the usual pattern, unexplained microcytosis (small red cells), or a family history of hemoglobin disorders from Southeast Asia. Test before pregnancy or early in pregnancy to guide partner testing, prenatal options, and newborn planning. People with known Hemoglobin E trait/disease should test to assess coinherited variants like beta-thalassemia.
Diagnosis
When fatigue, pale skin, or slower weight gain in a child raise questions, doctors look for patterns that point toward a lifelong, inherited blood condition. With Hemoglobin E disease, clues often include mild anemia and small red blood cells, and these clinical features are then confirmed with specific lab tests. Many people feel relief just knowing what’s really going on. Doctors combine a blood count, a look at the cells under a microscope, and specialized hemoglobin tests, and sometimes genetic tests, to make a clear diagnosis.
Providers look for signs of mild anemia such as tiredness, paler skin, or a new heart murmur. Growth and development are usually typical, and severe symptoms are uncommon.
A CBC often shows a low hemoglobin level with small red blood cells. This pattern helps raise suspicion for Hemoglobin E disease and related hemoglobin conditions.
A technologist examines the shape and color of red cells on a slide. Target cells and other subtle changes can support Hemoglobin E disease when seen alongside other tests.
This test separates the different types of hemoglobin in the blood. Finding a high proportion of hemoglobin E confirms the diagnosis of Hemoglobin E disease.
Stages of Hemoglobin e disease
Hemoglobin e disease does not have defined progression stages. In most people it tends to stay fairly steady over time, and how it shows up depends on whether HbE is present by itself or together with another hemoglobin change, which affects severity but not in stepwise phases. When early symptoms of Hemoglobin e disease such as tiredness or pale skin raise concern, clinicians usually start with a complete blood count and review red blood cell size. Different tests may be suggested to help confirm the type—often hemoglobin analysis and, at times, genetic testing—and to plan monitoring.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after being told they have Hemoglobin E disease. For most people with Hemoglobin E disease, life expectancy is normal, and daily life is minimally affected. Mild anemia is common, which can mean a bit more tiredness on busy days or after an illness, but many living with Hemoglobin E disease feel well between checkups. Everyone’s journey looks a little different.
Prognosis refers to how a condition tends to change or stabilize over time. In Hemoglobin E disease, the outlook is generally very good if it occurs on its own, without another hemoglobin change. Serious complications are uncommon, and most people do not need regular transfusions. When Hemoglobin E is combined with beta thalassemia (sometimes called HbE/β-thalassemia), the picture is more variable and can range from mild to severe, including a higher chance of transfusion needs and, rarely, heart or infection risks that can affect mortality.
Looking at the long-term picture can be helpful. Early symptoms of Hemoglobin E disease are often mild—pale skin, fatigue, or slight jaundice—and they may flare during infections, pregnancy, or significant stress. Good nutrition, folate as advised, and prompt treatment of infections help reduce dips in hemoglobin. With ongoing care, many people maintain steady energy and avoid complications.
Talk with your doctor about what your personal outlook might look like. If Hemoglobin E disease runs in the family or if a partner has a different hemoglobin trait, genetic testing can sometimes provide more insight into prognosis for future children. Keep regular appointments—small adjustments can improve long-term health. Understanding the prognosis can guide planning and help you and your family feel prepared rather than worried.
Long-term effects
Hemoglobin E disease is usually a mild, lifelong red blood cell condition, but outlook depends on the specific hemoglobin pattern. Long-term effects vary widely, with many people having few day-to-day issues while others face complications more commonly seen when Hemoglobin E is combined with beta thalassemia (HbE/β‑thalassemia). Questions about life expectancy with Hemoglobin E disease are common, and most people with HbE alone have a normal lifespan. In contrast, HbE/β‑thalassemia can lead to moderate or severe anemia and related complications over time.
Mild anemia is common and often lifelong. Many feel normal between occasional low‑energy days. Red blood cells are smaller but usually move enough oxygen for everyday needs.
Ongoing red cell breakdown can cause mild yellowing of the eyes or skin at times. This may come and go with infections, dehydration, or stress.
Lifelong hemolysis raises the chance of pigment gallstones. People may notice right‑upper belly pain, nausea, or episodes of biliary colic if stones form.
The spleen can remain enlarged over years. Fullness under the left ribs or lower blood counts may occur.
How is it to live with Hemoglobin e disease?
Day to day, many living with Hemoglobin E disease balance periods of good energy with times of fatigue, headaches, or shortness of breath, especially during illness, dehydration, or heavy exertion. Some need occasional medical visits for blood counts, folate, or transfusions, and may plan around heat, high altitudes, or infections that can trigger anemia symptoms. Family, friends, and coworkers often adjust by offering flexibility for rest, clinic appointments, or travel timing, and learn simple cues—like noticing when you look pale or tire easily—to help without hovering. For many, understanding the condition, staying hydrated, keeping vaccines current, and pacing activities keeps life full, with most routines, school, work, and relationships continuing with a bit of extra planning.
Treatment and drugs
Hemoglobin E disease is usually mild, so treatment focuses on comfort and preventing complications rather than heavy medication. Many people with Hemoglobin E disease need little more than regular checkups, a complete blood count from time to time, and vaccines and infection prevention similar to anyone with mild anemia. If anemia becomes more noticeable—fatigue, pale skin, shortness of breath with exertion—doctors may suggest folic acid supplements to support red blood cell production, and treat any triggers like infections; blood transfusions are rarely needed except during severe illness, pregnancy complications, or surgery. Supportive care can make a real difference in how you feel day to day. Your doctor may also screen for iron overload before recommending iron, since unnecessary iron can build up in the body.
Non-drug treatment
Non-drug care for Hemoglobin E disease focuses on staying well, keeping energy up, and catching issues early. Non-drug treatments often lay the foundation for day-to-day stability alongside any medical care you may need. The main tools include regular monitoring, smart infection prevention, tailored nutrition, and supportive planning at school, work, and home. Genetic counseling can also help you understand inheritance and future family risks.
Routine visits help track blood counts, growth, and spleen size. This monitoring can catch early symptoms of Hemoglobin E disease before they snowball.
Staying up to date lowers the risk of serious infections. Your care team may follow an enhanced schedule if your spleen is enlarged.
A diet rich in fruits, vegetables, and folate-containing foods supports red blood cell production. Avoid iron supplements unless your clinician confirms you need them.
Drinking enough water can ease headaches and fatigue linked to anemia. Aim for steady fluids through the day, and more in hot weather or during illness.
Your genes may have an impact on how drugs work for you
Medicines for Hemoglobin E disease can work differently based on genes that affect how fast your body processes drugs and how your red blood cells behave. Genetic differences may change needed doses, side‑effect risks, and whether treatments like folate or transfusions help.
Pharmacological treatments
Most people living with Hemoglobin E disease have mild anemia and may not need regular medicine. When treatment is needed—more often in Hemoglobin E/β‑thalassemia—the goal is to support red blood cell production, prevent iron overload from transfusions, and reduce transfusion needs. Not everyone responds to the same medication in the same way. Early symptoms of Hemoglobin E disease are often mild, but medicines can help if anemia becomes significant or if transfusions lead to extra iron in the body.
This daily vitamin supports red blood cell production when your bone marrow is working harder. It is commonly used in Hemoglobin E disease to help maintain hemoglobin levels. Side effects are uncommon at standard doses.
This medicine can raise fetal hemoglobin, which may ease anemia in some with Hemoglobin E/β‑thalassemia. Doctors may start low and adjust based on blood counts. Regular lab checks help keep treatment safe.
This injection (every 3 weeks) can reduce transfusion needs in transfusion‑dependent beta‑thalassemia, including some people with Hemoglobin E/β‑thalassemia. It works by helping red blood cells mature more effectively. Your care team will monitor for blood pressure changes and other side effects.
This oral iron chelator removes excess iron that builds up from repeated transfusions in Hemoglobin E disease. Dosing may be increased or lowered gradually to balance benefits and side effects. Kidney and liver tests are checked regularly.
Genetic influences
Hemoglobin E disease is inherited in a recessive way—most people develop it only if they receive the hemoglobin E gene change from both parents. Those with one copy are carriers and usually have no symptoms; this is often called hemoglobin E trait. If a hemoglobin E change pairs with a different beta-globin change, such as beta thalassemia, a child may have hemoglobin E/beta thalassemia, which can be more serious. Having a gene change doesn’t always mean you will develop the condition. Genetic testing for hemoglobin E disease can confirm the specific gene changes and help clarify carrier status for partners planning a family. The hemoglobin E variant is more common in people with Southeast Asian ancestry, but because families move and mix, it’s found worldwide.
Is Hemoglobin e disease genetic?
Genetics is central in Hemoglobin E disease. It happens when someone inherits Hemoglobin E variants from both parents; carriers usually have mild or no symptoms. Different genetic combinations (e.g., HbE with beta-thalassemia) can change severity and management.
Pharmacogenetics—how genetics influence drug effects
In Hemoglobin E disease, inherited hemoglobin changes can shape how aggressive treatment needs to be and which medicines are likely to help. If HbE is paired with beta thalassemia, doctors may consider hydroxyurea; people who naturally make more fetal hemoglobin due to certain inherited markers tend to respond better, while others may see limited benefit. Not every difference in response is genetic, but certain gene patterns can affect how well you tolerate iron chelators or how likely you are to develop jaundice while taking them. Genes can also inform transfusion care: extended blood group typing based on your DNA can reduce reactions and make it easier to find compatible units over time. Testing for G6PD deficiency matters too, because some antibiotics, antimalarials, and other oxidant drugs can trigger extra breakdown of red blood cells in people with that enzyme problem. Overall, understanding how genetics affect treatment of Hemoglobin E disease helps tailor choices—dose and monitoring for chelation, realistic expectations with hydroxyurea, and safer transfusion strategies.
Interactions with other conditions
Living with Hemoglobin E disease, many notice anemia symptoms flare during infections, after surgery, or in pregnancy, when the body’s demand for red blood cells rises. Doctors call it a “comorbidity” when two conditions occur together. The most important interaction is with thalassemia: Hemoglobin E disease and thalassemia can combine as Hemoglobin E/β‑thalassemia, which often causes more severe anemia and may require regular transfusions, while co‑inherited alpha‑thalassemia can sometimes soften the anemia a bit. Another notable pairing is G6PD deficiency; certain antibiotics, antimalarials, or even fava beans can trigger sudden red‑cell breakdown, so care teams usually review medicines carefully and give clear avoidance advice. In regions with malaria, some studies suggest Hemoglobin E may offer partial protection, but malaria and other infections can still worsen anemia, making prevention and early treatment especially important. Iron issues also intersect here: iron deficiency is common worldwide and can look similar on lab tests, while frequent transfusions for Hemoglobin E/β‑thalassemia can lead to iron overload—so iron supplements should only be used if tests confirm low iron stores.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of children who tired easily, looked a bit pale or yellow, and had bellies that seemed fuller from a young age. In parts of Southeast Asia, especially Thailand, Cambodia, Laos, and nearby regions, these stories appeared again and again across villages and generations. Travel and migration later carried similar accounts to Europe, North America, and Australia, where clinicians began to connect these family stories with lab findings.
First described in the medical literature as an unusual form of inherited anemia in the mid-20th century, Hemoglobin E disease drew attention because routine blood counts looked different—red cells were smaller than expected, yet many children were otherwise active and growing. Early reports called it “Hemoglobin E trait” when only one copy of the change was present, and “Hemoglobin E disease” when two copies were inherited, though the terminology has been refined as doctors learned how often it overlaps with other hemoglobin changes such as beta thalassemia.
From early theories to modern research, the story of Hemoglobin E disease shows how careful observation can guide science. Clinicians first recognized where it clustered geographically, then family studies showed the inheritance pattern. As medical science evolved, protein testing confirmed that the hemoglobin itself had a distinct form, and later DNA methods pinpointed the exact change in the beta-globin gene. With each decade, testing became more accurate and available, helping families understand who carried the change and who might develop symptoms.
In recent decades, awareness has grown that Hemoglobin E disease ranges widely in severity. Many living with Hemoglobin E disease have mild anemia and few day-to-day limits, while others—especially those with combined forms like Hemoglobin E/beta thalassemia—may need closer monitoring, folate support, or transfusions at times. These historical steps also shaped newborn screening in some regions, added it to premarital or prenatal panels in others, and improved counseling for couples planning a pregnancy.
Not every early description was complete, yet together they built the foundation of today’s knowledge. Doctors now recognize telltale features on a blood smear, confirm the type with hemoglobin analysis, and, when needed, use genetic testing to clarify the exact form. For many, this history explains why a condition once thought rare in Western clinics is now commonly identified in multicultural communities. Knowing the condition’s history helps set expectations: most children with Hemoglobin E disease thrive with routine care, and families can make informed choices with clear, timely information.